| Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 207.18M | 102.54M | 189.43M | 337.37M | 311.75M |
| Gross Profit | 36.24M | 9.41M | 15.12M | 56.12M | 48.82M |
| EBITDA | 9.17M | -27.86M | -15.99M | 20.00M | 15.56M |
| Net Income | 1.32M | -36.72M | -23.21M | 13.74M | 11.30M |
Balance Sheet | |||||
| Total Assets | 194.37M | 169.54M | 231.16M | 252.69M | 233.33M |
| Cash, Cash Equivalents and Short-Term Investments | 8.01M | 33.58M | 26.55M | 28.99M | 41.62M |
| Total Debt | 55.53M | 53.04M | 66.50M | 48.66M | 36.48M |
| Total Liabilities | 100.68M | 77.18M | 102.08M | 96.40M | 76.78M |
| Stockholders Equity | 93.68M | 92.37M | 129.08M | 156.29M | 156.55M |
Cash Flow | |||||
| Free Cash Flow | -8.87M | 23.54M | -11.18M | -10.25M | 21.61M |
| Operating Cash Flow | -8.85M | 24.29M | -10.74M | -8.92M | 22.77M |
| Investing Cash Flow | -9.58M | -701.00K | -424.00K | -1.33M | -32.93M |
| Financing Cash Flow | -3.26M | -18.66M | 7.71M | -3.14M | -7.55M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$386.15M | 6.68 | 18.10% | 12.50% | 5.55% | -18.91% | |
71 Outperform | HK$199.29M | -99.45 | -0.14% | 5.26% | 9.48% | -53.42% | |
65 Neutral | HK$177.50M | 4.65 | 5.52% | 9.71% | 27.42% | -32.34% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
51 Neutral | HK$268.91M | -14.68 | -6.83% | 8.33% | 0.94% | 82.30% | |
49 Neutral | HK$592.00M | 50.45 | 0.48% | ― | 144.67% | ― |